You are hereHome
- Keynote Speaker
- October 11, 2017
- 8:00 AM to 4:15 PM
- Toronto Reference Library
789 Yonge Street, one block north Bloor Street
Toronto General Hospital Research Institute (TGHRI) is happy to announce that this year’s Research Day will be held on Wednesday October 11th, 2017 at the Toronto Reference Library, 789 Yonge Street, Toronto.
This year we will have two keynote speakers:
Dr. Ronald Cohn, Chief of the Division of Clinical and Metabolic Genetics, Co-Director of the Centre for Genetic Medicine, and Senior Scientist at the SickKids Research Institute will be presenting “Interventional Genomics: A new era on the horizon”
Dr. Eleftherios P. Diamandis, Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network and Professor & Head, Clinical Biochemistry, Department of Laboratory Medicine and Pathobiology, University of Toronto will be presenting “Of Theranos, Scientific Irreproducibility and Other Matters: Lessons and Solutions”
This event is a celebration of TGHRI achievements in basic and clinical research and an opportunity to promote interdepartmental and cross pillar collaborations among researchers. TGHRI Research Day is open to all TGHRI Scientists, Clinician Scientists, trainees and staff. Undergraduate students, MSc students, PhD students, and postdoctoral fellows are invited to submit a first-author abstract of their research, either completed or in progress to the Research Day poster competition. To highlight TGHRI’s many areas of research and to encourage collaboration and discussions between groups, all abstracts submitted will be published in our Research Day booklet. As done last year, the first round of poster judging will take place prior to Research Day. The TGHRI leadership team and TGHRI faculty and staff will grade the abstracts and up to 59 abstracts will be accepted as posters. Those with the highest ranked abstracts will be asked to give a brief presentation of their posters during Research Day, and the winners will be presented with an award.
Abstract submissions are due by Friday September 8th, 2017. Abstract submission is part of the registration process; if you plan to submit an abstract, DO NOT register until your abstract is ready. If you are not submitting an abstract, please register as a General Attendee as soon as possible.
General registration closes September 15th, 2017.
Online registration is mandatory so the proper seating, catering, and materials can be provided.
TGHRI Research Day 2016 is organized by the TGHRI Directorate (TGH, 1N-121) firstname.lastname@example.org/416-581-7660. Please contact Tracy McQuire with any questions.
Dr. Ronald Cohn
"Interventional Genomics: A new era on the horizon"
Dr. Ronald Cohn joined The Hospital for Sick Children in September 2012 as the Chief of the Division of Clinical and Metabolic Genetics, Co-Director of the Centre for Genetic Medicine, and Senior Scientist at the SickKids Research Institute. He became the Inaugural Women’s Auxiliary Chair in Clinical and Metabolic Genetics in April of 2013, as well as joining the department of Molecular Genetics at the University of Toronto. On July 1st, 2016 Ronald Cohn was appointed to the position of Chief of Paediatrics at The Hospital for Sick Children, and Chair of Paediatrics at The University of Toronto.
Dr. Cohn received his medical degree from the University of Essen, Germany. After his postdoctoral fellowship at the Howard Hughes Medical Institute in the laboratory of Dr. Kevin Campbell, he moved to Baltimore where he was the first combined resident in paediatrics and genetics at the Johns Hopkins University. He subsequently joined the faculty of the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins where he became the director of the worlds' first multidisciplinary centre for Hypotonia, which has earned national and international recognition. Dr. Cohn was also the director of the medical genetics residency program at Johns Hopkins. He has received numerous awards including the David M. Kamsler Award for outstanding compassionate and expert care of pediatric patients in 2004; First Annual Harvard-Partners Center for Genetics and Genomics Award in Medical in 2006; and the NIH Young Innovator Award in 2008
Dr Eleftherios P. Diamandis, MD, PhD.
"Of Theranos, Scientific Irreproducibility and Other Matters: Lessons and Solutions"
Dr. Diamandis currently serves as Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network and is Professor & Head, Clinical Biochemistry, Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada. His research activities evolve around discovery and validation of cancer biomarkers, proteomics, mass spectrometry and translational research.
Dr. Diamandis received his B.Sc. in Chemistry, Ph.D. in Analytical Chemistry and M.D. from the University of Athens, Greece and a Diploma in Clinical Biochemistry from the University of Toronto, Canada. He is a Certified Clinical Chemist by the Canadian Academy of Clinical Biochemistry and the American Board of Clinical Chemistry.
Dr. Diamandis is a Member of 45 Journal Advisory Scientific and Editorial Boards, including The Journal of Biological Chemistry, Cancer Research, Molecular Cancer Research, Journal of Clinical Oncology, Clinical Chemistry and Journal of Proteome Research. He has received numerous awards from both national and international organizations, including more recently: Senior Sustained Excellence in Graduate Teaching Award, Faulty of Medicine, University of Toronto (2013); Carl Joliff Award for Lifetime Achievement in Clinical and Diagnostic Immunology (2013); CCSC Award for Outstanding Contributions to Clinical Chemistry (2014) and The JJ Berry Smith Award for Doctoral Supervision, University of Toronto, Canada (2014). Dr. Diamandis is highlighted for his citation record in: The Provincial Government of Ontario document entitled “Ontario’s Innovation Agenda” (2010), [www.ontario.ca/innovation; page 11]. He has more than 50,000 lifetime citation and an H-index of 111.
Other major distinctions of Dr. Diamandis include his election as Corresponding Member of the Academy of Athens, Greece (2005), Member of the Royal Society of Canada (2008), Fellow of the American Association for the Advancement of Science (2011) and Fellow of the Canadian Academy of Health of the Sciences (2012). He has published 133 review papers, over 600 research papers and co-authored 4 books and 42 book chapters. He is the inventor of 28 issue and 26 pending patents and supervised 22 MSc. and 35 PhD. theses.
TGHRI Research Day 2017
Wednesday October 11th, 2017
|8:00 – 9:00 AM||Registration and breakfast, poster set-up
|9:00 – 9:30 AM||Welcome: Year in Review
Mansoor Husain, Director, TGHRI
EVP Introduction: Dr. Bradly G. Wouters
|9:30 – 11:40 AM
||Oral Session I
|(9:30 – 10:20 AM)||Keynote Speaker #1
Ronald Cohn, The Hospital for Sick Children
Interventional Genomics: A new era on the horizon
||TDC Mini Presentation, Poster Session Room|
|10:40 – 11:10 AM)
(11:10– 11:30 AM)
|(11:30 – 11:50 AM)||Beate Sander
Support, Systems and Outcomes
|11:50 – 12:20 PM||Moderated Poster PRESENTATIONS AND Judging (Odd Numbers)
Mini presentation: TDC - Poster session room
|12:20 – 1:15 PM
||Lunch, Poster Viewing|
|1:15 – 1:45 PM||Moderated Poster PRESENTATIONS AND Judging (Even Numbers)
Mini presentation: Facilities planning and Core
|1:45 – 3:50 PM||Oral Session II
Chair: Mansoor Husain
|(1:45 – 2:15PM)
|Glycoprotein 2 is a specific cell surface marker of human pancreatic progenitors|
|(2:15 – 2:45 PM)||Myron Cybulsky
|(2:45 – 3:00 PM)
||Coffee Break||Facilities, Core Facilities Mini Presentation, Poster Session Room|
|(3:00 – 3:50 PM)
||Keynote Speaker #1
Eleftherios P. Diamandis, Mount Sinai Hospital
Of Theranos, Scientific Irreproducibility and Other Matters: Lessons and Solutions
|3:50 – 4:10 PM||TGHRI Postdoctoral Fellow Awards
Poster Competition Awards
Presented by: Dr. Mansoor Husain, Director, TGHRI
Abstract submissions are due by September 8th, 2017.
No late submissions will be accepted.
If you wish to submit a first-authored abstract for the poster presentation, please note that abstract submission and registration are part of the same process. Please register only if your abstract is also ready for submission.
All posters submitted will be published in the Research Day booklet. As done last year, poster participants will be selected and front runners will be announced by TGHRI leadership prior to Research Day. TGHRI directorate will notify you by September 15th, 2017 if your abstract has been accepted and if you have been selected to give a brief presentation of your poster on Research Day for the final round of judging.
Poster Details: Maximum size (height x length): 3' x 6' (36" x 72") (1m x 2m)
Abstract Authors: Please type in all names using the first initial followed by the author's last name. A comma should separate author names. The final name should be followed by a period.
For example: SR Wilson, MK O'Reilly, JP Leduc, and BA Bell.
Affiliations: Please type in all affiliations. A comma should separate each affiliation. The final affiliation should be followed by a period.
For example: Toronto General Research Institute, Toronto, ON and University of Toronto, Toronto, ON.
Abstract: Abstracts are limited to 2000 characters with spaces. Proofread your abstract for accuracy.
Poster space is limited; only one first-authored abstract per registrant may be submitted.
Abstracts will be accepted from undergraduate students, MSc students, PhD students, and postdoctoral fellows. You must be the presenting author and first author in order to be judged in the poster competition.
The TGHRI Research Day will be held at the Toronto Reference Library, 789 Yonge Street, Toronto, ON. The venue is one block north on Bloor Street on the east side of Yonge Street.
Research Day comments and inquiries:
Tracy McQuire, TGHRI Business Officer – email@example.com or 416-581-7660